Market Place
Sourcing Support
Shuttle Pharma Doses First Patients in Glioblastoma Trial
29 Oct 2024 //
GLOBENEWSWIRE
Shuttle Pharma Expands Trial For Glioblastoma Treatment
16 Sep 2024 //
GLOBENEWSWIRE
Shuttle Pharma Provides Second Quarter 2024 Corporate Update
04 Sep 2024 //
GLOBENEWSWIRE
Plus Therapeutics Reports Q2 2024 Financial Results And Business Highlights
14 Aug 2024 //
GLOBENEWSWIRE
Shuttle Receives FDA Approval to Proceed with Phase II Trial of Ropidoxuridine
08 Jan 2024 //
PR NEWSWIRE
Shuttle Pharma Submits IND Application to the U.S. FDA for Ropidoxuridin
11 Dec 2023 //
PR NEWSWIRE
Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine
25 Sep 2023 //
PR NEWSWIRE
Shuttle Pharmaceuticals Engages UI Pharmaceuticals for Ropidoxuridine
09 Mar 2023 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.